ALNYLAM PHARMACEUTICALS, INC. Business Operations Contracts & Agreements

33 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 2 to License and Collaboration Agreement, dated as of October 31, 2022 between the Registrant and The Medicines Company
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2023
License and Collaboration Agreement dated as of February 3, 2013 by and among The Medicines Company and the Registrant
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2023
Amendment to License and Collaboration Agreement, dated as of November 22, 2019 between the Registrant and The Medicines Company
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2020
Amendment No. 3 entered into as of April 8, 2019 to the Master Collaboration Agreement dated as of January 11, 2014, as amended by Amendment No. 1 and Amendment No. 2, including...
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2019
Manufacturing Services Agreement effective as of March 28, 2018 by and between the Registrant and Agilent Technologies, Inc
Services Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2018
Amendment No. 2 entered into as of January 6, 2018 to the Master Collaboration Agreement dated as of January 11, 2014, as amended by Amendment No. 1, including certain Regional,...
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2018
FORM OF DIRECTOR INDEMNIFICATION AGREEMENT
Indemnification Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
DE
2016
AMENDED AND RESTATED DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT
Development Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2015
AMENDMENTNUMBER ONE TO THE SECOND AMENDED AND RESTATED STRATEGIC COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2015
AMENDMENT NO. 1 TO MASTER COLLABORATION AGREEMENT
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2015
CONFIDENTIAL SETTLEMENT AGREEMENT AND MUTUAL RELEASE
Settlement Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2015
AMENDMENT TO THE RESEARCH COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2015
SECOND AMENDEDAND RESTATED STRATEGIC COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
DE
2015
MASTER SERVICES AGREEMENT Between Medpace, Inc. an Ohio Corporation 4620 WesleyAvenue Cincinnati, Ohio 45212 (MEDPACE) and Alnylam Pharmaceuticals, Inc. 300Third Street Cambridge,...
Services Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2014
LICENSE AND COLLABORATION AGREEMENT by and between ALNYLAM PHARMACEUTICALS, INC. and THE MEDICINES COMPANY
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2013
EX-10.40 First Amendment to License and Collaboration Agreement entered into as of November 2, 2009
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2010
EX-10.39 Collaboration Agreement entered into as of October 29, 2009
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2010
Ex-10.3 Amended and Restated Strategic Collaboration and License Agreement effective as of April 28, 2009 between Isis Pharmaceuticals, Inc. and the Registrant
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
DE
2009
Ex-10.2 License and Collaboration Agreement between the Registrant and Cubist
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2009
Ex-10.26 License and Collaboration Agreement
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2009
Ex-10.23 Research Collaboration and License Agreement
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2009
Ex-10.7 Termination Agreement, dated as of September 18, 2007, by and between Merck & Co., Inc. and the Registrant
Termination Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2007
Ex-10.5 License and Collaboration Agreement, entered into as of September 6, 2007, by and among the Registrant, Isis Pharmaceuticals, Inc. and Regulus Therapeutics LLC
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
DE
2007
Ex-10.4 Amended and Restated Collaboration Agreement, entered into as of July 27, 2007, by and between the Registrant and Medtronic, Inc
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
DE
2007
Ex-10.1 License and Collaboration Agreement, entered into as of July 8, 2007, by and among F. Hoffmann-La Roche, Ltd, Hoffman-La Roche Inc., the Registrant and, for limited...
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2007
Ex-10.1 Collaboration and License Agreement by and between the Registrant and Biogen Idec MA. Inc. dated September 20, 2006
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2006
EX-10.2 TERMINATION AGREEMENT
Termination Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2006
EX-10.1 AMEND. & RESTATED RESEARCH COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2006
EX-10.1 RESEARCH COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2005
EX-10.3 RESEARCH COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2005
Ex-10.1 Collaboration Agreement effective as of February 8, 2005
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
DE
2005
EX-10.1 COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2004
EX-10.24 STRATEGIC COLLABORATION & LICENSE
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
DE
2004